Medication info
Alviks Tablet 20 mg (Memantine Hydrochloride)

Alviks Tablet 20 mg (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›20mg / 1 tablet
Manufacturer / importer
Korea Pharma Co., Ltd.
Appearance
Orange rectangular film-coated tablets
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 202401543 · Approved 2024.06.26 · Insurance code 653006970

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medicine is administered orally once daily at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7): Administer 5mg once daily for 7 days. Week 2 (Days 8–14): Administer 10mg once daily for 7 days. Week 3 (Days 15–21): Administer 15mg once daily for 7 days. From Week 4 onward: Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults Based on clinical data, the recommended dose for older patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), reduce the daily dose to 10mg. After at least 7 days of treatment, if well tolerated, the dose may be increased to 20mg once daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Korea Pharma Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used for the treatment of moderate to severe Alzheimer's disease.

How to take

Adult dose

This medicine is administered orally once daily at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7): Administer 5mg once daily for 7 days. Week 2 (Days 8–14): Administer 10mg once daily for 7 days. Week 3 (Days 15–21): Administer 15mg once daily for 7 days. From Week 4 onward: Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults Based on clinical data, the recommended dose for older patients aged 65 years or older is 20mg once daily. 3. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance: 30-49 mL/min), reduce the daily dose to 10mg. After at least 7 days of treatment, if well tolerated, the dose may be increased to 20mg once daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance: 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.

Precautions

This medication should not be administered to patients with an allergy to its components. Patients with very poor liver or kidney function should also not use this medication. Administration is prohibited, particularly in cases of severely impaired kidney function. Caution should be exercised when using this medication in patients with epilepsy, those who have previously experienced seizures, or those at risk of seizures. Concomitant use with medications that have similar effects, such as amantadine, ketamine, and dextromethorphan, may increase the risk of side effects; therefore, such combinations should be avoided. Patients who have factors or conditions that affect urinary acidity (pH) should be closely monitored while taking this medication. In patients with recent myocardial infarction, heart failure, or uncontrolled hypertension, the safety of this medication has not been sufficiently proven, so it should be administered with caution. Patients allergic to the dye Yellow No. 5 included in this medication should also be cautious. Side effects such as dizziness, headache, constipation, drowsiness, and hypertension may occur, and if these symptoms are severe, a physician should be consulted. In addition, psychiatric adverse reactions or neurological symptoms like hallucinations and confusion may rarely appear. This medication may interact with other drugs, so if you are taking other medications, it is essential to inform your physician or pharmacist. Caution is particularly necessary when taken with anticholinergic drugs, antipsychotic drugs, skeletal muscle relaxants, and anticoagulants. Women who are pregnant or may become pregnant should carefully consider the risks and benefits of using this medication, and it is advisable to stop breastfeeding if nursing. This medication is not to be used in children or adolescents under 18 years of age, as its safety and efficacy have not been established. In case of overdose, symptoms such as confusion, drowsiness, dizziness, vomiting, and diarrhea may occur, and immediate medical attention should be sought. This medication can affect the patient's concentration and reaction speed; therefore, special care should be taken when driving or operating machinery. Finally, this medication should be kept out of reach of children and should not be transferred to other containers.

Side effects

Dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that prevents air or moisture from entering, at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain the medication's efficacy and ensure safe usage.

Appearance and packaging

Appearance

Orange rectangular film-coated tablets

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.